Navigation Links
Marken Announces Appointment of Christopher O'Connell as New Chief Financial Officer
Date:8/9/2011

LONDON, Aug. 9, 2011 /PRNewswire/ -- Marken Ltd., a leading life sciences supply chain management organization, today announced the appointment of Christopher O'Connell as their new Chief Financial Officer (CFO) effective August 1, 2011.

Mr. O'Connell joins Marken with more than 20 years experience in the laboratory manufacturing and distribution services, construction and public accounting industries. He most recently worked for Thermo Fisher Scientific as Vice President of Finance for the Customer Channels Group, a multi-billion dollar, multi-national laboratory distribution and services group.  Thermo Fisher serves pharmaceutical and biotech companies, hospitals, clinical diagnostic labs, universities, research institutions and government agencies and has a portfolio of over 800,000 products.  

Mr. O'Connell also served Fisher in various roles which involved the development of the company's portfolio strategies, acquisitions and integration of new companies, management of shared service functions as well as having full income statement responsibilities across multiple business lines.  

"Chris' business insight, combined with his extensive financial leadership, acquisition integration expertise and pharmaceutical services and supplies familiarity at Thermo Fisher, make him an excellent addition to our executive leadership team. Our business expansion strategies will benefit enormously from Chris's background and leadership qualities." said Wes Wheeler, Chief Executive Officer of Marken.

Mr. O'Connell holds a Bachelor of Business Administration from Siena College and is a Certified Public Accountant.

About Marken

Founded in 1980, Marken is focused on supporting life science companies by managing their clinical supply chain and logistics through the entire clinical trial process. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naïve geographies. As the leading logistics company managing global collection, transportation, storage and distribution of specimens and clinical trial supplies, Marken supports the clinical supply chain to over 6000 investigator sites in excess of 100 countries. Marken's team members and network of facilities bridge the distance between patients and the essential resources of life science companies.


'/>"/>
SOURCE Marken
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Announces the Opening of a Directly Owned Clinical Trial Supply Depot in Singapore
2. Marken Rapidly Responds to Global Supply Chain Security Measures
3. Marken Unveils New Japan Office
4. MedShape Solutions Announces FDA 510(k) Clearance of Innovative Ankle Fusion Device
5. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
6. Cepheid Announces Release of Updated Xpert BCR-ABL Monitor Test
7. Galil Medical Announces Reimbursement for Small Renal Cancer Cryoablation in Japan
8. Pharmasset Announces Two-for-One Forward Stock Split
9. Mindray Announces Second Quarter 2011 Financial Results
10. Boston Scientific Announces Favorable Court Ruling Dismissing Securities Fraud Case
11. K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... TORONTO , March 28, 2017 /PRNewswire/ - ... service medical device development firm, announced today that it ... Toronto -based medical device industrial design and productization ... companies throughout North America with ... device talent spanning the design, engineering, regulatory, and manufacturing ...
(Date:3/28/2017)... and TEL AVIV, Israel , March 28, 2017 ... Israel . This new business entity, Emosis Ltd, ... dedicated to research and development of novel assays complementing the mother ... when relevant, locally support commercialization and sales development of Emosis kits. ... This strategic move ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... 29, 2017 , ... The Wharton School of the University of Pennsylvania is ... made a $10 million gift to establish the Ken Moelis and Julie Taffet ... to a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests expand ...
(Date:3/28/2017)... ... 2017 , ... Tuesday, March 28, 2017, is the annual American Diabetes Association ... Test to find out if they are at risk for developing Type 2 diabetes. ... evening sky by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., ... invited to the Siemens Healthineers annual customer education symposium, a world-class learning conference ... place from March 27 - 31, 2017 at the Atlanta Marriott Marquis in ...
(Date:3/28/2017)... ... March 28, 2017 , ... City trips ... (IBT World Travel Trends Report). As travelers visit both urban destinations, they are ... and prolonged sun exposure. In response, the outdoor industry has blurred the lines ...
(Date:3/28/2017)... ... ... Sentry Group LLC., a leader in the Personal Emergency Response System industry, introduced advanced ... These iSAFE products are the most affordable and most advanced medical alert systems on ... GPS Location and two-way calling with the push of a button on a nationwide ...
Breaking Medicine News(10 mins):